Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10953982 | Journal of Molecular and Cellular Cardiology | 2010 | 9 Pages |
Abstract
Results and significance: ⺠The present study shows that the cardiac glycoside ouabain increases cytosolic Na+, blunts mitochondrial Ca2+ accumulation during increased work (β-adrenergic stimulation and electrical pacing), causes net oxidation of the NAD(P)H pool, increases reactive oxygen species accumulation, and causes triggered arrhythmias. ⺠The mitochondrial dysfunction caused by ouabain could be prevented by enhancing mitochondrial Ca2+ uptake with an inhibitor (CGP37157) of the mitochondrial Na+/Ca2+ exchanger (mNCE). ⺠CGP37157 effectively preserved mitochondrial function during ouabain administration, potentiating the positive inotropic actions of the glycoside (and β-adrenergic agonists) and mitigating the toxic effects in cells, perfused hearts, or intact animals. ⺠The results suggest that partial mNCE inhibition may represent a novel strategy for improving cardiac glycoside therapy in the context of heart failure.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Ting Liu, David A. Brown, Brian O'Rourke,